Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group
Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S.
Psychopharmacology Bulletin 25(3): 331-335
1989
ISSN/ISBN: 0048-5764 PMID: 2576316 Document Number: 327486
Document emailed within 1 workday
Related Documents
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347Hargreaves, W.A.; Kane, J.M.; Ninan, P.T.; Severe, J.B.; Woerner, M. 1989: Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 340-343
Nakayasu, N.; Seki, Y.; Harima, H. 1999: Age of onset, frequency of the development of symptoms, and treatment outcome in the early stage of schizophrenia--in search of guidelines for early diagnosis and treatment of schizophrenia Seishin Shinkeigaku Zasshi 101(11): 898-907
Kane, J.M. 1990: Treatment programme and long-term outcome in chronic schizophrenia Acta Psychiatrica Scandinavica. Supplementum 358: 151-157
Williams, J.; Spurlock, G.; McGuffin, P.; Mallet, J.; Nöthen, M.M.; Gill, M.; Aschauer, H.; Nylander, P.O.; Macciardi, F.; Owen, M.J. 1996: Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group Lancet 347(9011): 1294-1296
Allen, J.G.; Tarnoff, G.; Kearns, N.W.; Coyne, L. 1986: Paranoid versus nonparanoid schizophrenia and long-term hospital treatment outcome Bulletin of the Menninger Clinic 50(4): 341-350
Gelenberg, A.J.; Doller, J.C. 1979: Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study Journal of Clinical Psychiatry 40(5): 238-240
Burkovskiĭ, G.V.; Vuks, A.I.; Iovlev, B.V.; Korabel'nikov, K.V.; Shchelkova, O.I. 1990: Study of the effectiveness of individual computer-assisted prediction of the results of rehabilitation treatment of patients with schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(7): 94-99
Tsirkin, S.Iu. 1987: International study of schizophrenia based on a WHO program. Incidence of schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(8): 1203-1207
Arraras, J.I.; Basterra, I.; Pereda, N.; Ibañez, B.; Iribarren, S.; Cabases, J.M. 2019: The Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) questionnaire. A validation study with Spanish schizophrenia spectrum outpatients Actas Espanolas de Psiquiatria 47(3): 97-109
Baigent, L.; Ostbye, T.; Femando, M.L. 1999: Feasibility of client reports to measure treatment outcome in schizophrenia Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(1): 94-95
Kane, J.M.; Borenstein, M. 1985: Compliance in the long-term treatment of schizophrenia Psychopharmacology Bulletin 21(1): 23-27
Rollin, H.R. 1982: The long-term treatment of schizophrenia in the community Practitioner 226(1369): 1330-1333
Bouchard, R.H. 2002: Longitudinal comparative study of risperidone vs classical neuroleptics in the treatment of schizophrenia: 24 months of observation L'Encephale 28 Spec no 2 Pt 2: S31-S32
Welbel, L. 1980: Difficulties of evaluation of the results of drug treatment of schizophrenia Psychiatria Polska 14(1): 51-57
Bechelli, L.P.; Navas-Filho, F. 1986: Short-term double-blind trial of pipothiazine palmitate and haloperidol in the acute phase of schizophrenia L'Encephale 12(3): 121-125
Hartmann, W.; Meyer, J.E. 1974: Clinical treatment of chronic schizophrenia in the Federal German Republic. Results and consequences Der Nervenarzt 45(2): 1-8
Brook, S. 2003: Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia Journal of Clinical Psychiatry 64 Suppl. 19: 13-18
Lane, H.Y.; Chiu, W.C.; Chou, J.C.; Wu, S.T.; Su, M.H.; Chang, W.H. 2000: Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels Journal of Clinical Psychiatry 61(3): 209-214
Rosenbaum, B.; Bechgaard, B.; Borberg, S.; Burgaard, L.; Lauritsen, L.; Lindhardt, A.; Laerum, H.; Nystrup, J.; Winther, G. 1991: Psychotherapy of patients with schizophrenia. Study of the significance of group supervision Ugeskrift for Laeger 153(40): 2822-2825